MindMaze Therapeutics Holding S.A.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RLFTF research report →
Companymindmazetherapeutics.com
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland.
- CEO
- Zach W. Henderson
- IPO
- 2021
- Employees
- 31
- HQ
- Lausanne, CH
Price Chart
Growth & Income
- Revenue
- $8.42M · 39.52%
- Net Income
- $-17,119,000 · 82.56%
- EPS
- $-1.37 · 83.59%
- Op Income
- $-18,885,000
- FCF YoY
- 82.90%
Performance & Tape
- 52W High
- $4.88
- 52W Low
- $0.33
- 50D MA
- $0.47
- 200D MA
- $2.27
- Beta
- 1.14
- Avg Volume
- 3.85K
Get TickerSpark's AI analysis on RLFTF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our RLFTF Coverage
We haven't published any research on RLFTF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RLFTF Report →